Study Unveils Botox Ineffective In Case Of Headaches and Periodic Migraine


Study Unveils Botox Ineffective In Case Of Headaches and Periodic Migraine

As per recent findings, it has been suggested that the recommendation of botox for repetitive and periodic type of migraine and chronic tension type headaches, would be of no use, as the drug has not proved to be influential in such cases.

The drug was approved by the U. S. Food and Drug Administration (FDA) to be prescribed in cases of chronic migraines and no doubts it has been utilized, since a long time to reduce the sufferings in such cases, but it has failed for other similar conditions.

In order to acknowledge the effects of the drug, a team of researchers conducted a review, which analyzed the way Botox worked, in order to reduce the effect of migraines, tension or chronic daily headaches in adult patients.

Dr. Jeffrey L. Jackson of the Medical College of Wisconsin, Milwaukee, and his colleagues, who carried out the review, stated that their review categorized headaches into four categories: episodic (less than 15 per month), chronic (15 or more a month), and episodic or chronic daily or tension headaches.

Further, almost 27 random placebo trials were conducted on 5,300 patients that participated. The findings of the trials suggested that Botox was capable of reducing the amount of headaches per month in the cases, where the patients suffered from chronic daily headaches and chronic migraine headaches. However, other part of the story revealed that the drug failed to show any effects in case of patients who suffered from episodic migraines or chronic tension-type headaches.

The researchers said, "On average, patients who had chronic migraines and chronic daily headaches suffered two less headaches per month. The FDA approved injections reduced chronic headaches by about 10 percent".

However, the doctors who prescribe the drug state that it has shown significant results.

Latest News

U.S. Crude Drops Further Due to Surplus Supply
CVC and CPPIB Outbid Others for a Possible Deal to Buy Petco for $4.7 Billion
US Government All Set to Introduce a New Law for Americans “Seriously Delinquent
Reportedly Pfizer Plans to Acquire Allergan in a Deal of $150 Billion or More
In October Most States Experienced a Drop in Unemployment Rate
San Francisco Fed President John Williams sees a “Strong Case” for an Interest
Cincinnati Shoppers have More Choice of Local Black Friday Deals this Year
Sliding Crude Prices Continue Giving the U.S Oil Producers Reasons to Cut Costs
American Airlines Revamps its Much Anticipated Loyalty Reward Program
Report says, Many Retailers Recycling Black Friday Deals
Optimistic Sales Posted by Retailers Walmart, Home Depot and TJX Spark a Positiv
Interest Rate Hike a Possibility or Not in December, is Still a matter